Summary & Overview
CPT 56501: Destruction of Simple Lesions, Female External Genitalia
CPT code 56501 represents destruction or eradication of simple lesions on the external female genitalia by laser, electrical current, cryotherapy, or chemical application. This commonly performed minor surgical procedure addresses symptomatic lesions and can limit spread of infectious or premalignant lesions, making it clinically and operationally significant across outpatient and office-based settings. Nationally, this code is used by dermatology, gynecology, and general surgery practices and is relevant for policy and coverage determinations tied to procedural site, diagnosis linkage, and documentation standards.
Key payers referenced include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of the code’s clinical intent and typical sites of service, guidance on payer coverage considerations, and benchmarking context where available. The publication also summarizes common modifiers and operational coding considerations and highlights clinical scenarios that commonly map to the code. Data not available in the input will be noted where applicable. The content is intended to inform coding, revenue cycle, and clinical teams about the purpose and common use cases for CPT code 56501 in national practice settings.
Billing Code Overview
CPT code 56501 describes removal or destruction of one or more simple lesions on the external female genitalia using laser, electrical current, freezing, or chemical application. The procedure is intended to relieve patient discomfort and, for certain lesion types, to prevent spread.
-
Service type: Minor surgical lesion destruction / dermatologic procedure on external female genitalia
-
Typical site of service: Ambulatory surgical center, hospital outpatient department, or office-based procedure setting
Clinical & Coding Specifications
Clinical Context
A typical patient is a reproductive-age woman presenting to an outpatient gynecology clinic with one or more symptomatic superficial lesions on the external female genitalia (labia majora, labia minora, or perineum). Common presentations include painful or pruritic warts (HPV-related condyloma acuminata), symptomatic epidermal inclusion cysts, molluscum contagiosum, actinic or benign keratoses causing irritation, or small vulvar papillomas. The patient interview documents lesion onset, symptoms (pain, bleeding, discharge, pruritus), prior treatments, bleeding risk, and contraception or pregnancy status. A focused physical exam documents lesion size, number, location, morphology, and obtains informed consent for destructive removal. Appropriate preprocedure steps include reviewing anticoagulation status, pregnancy testing when indicated, and topical or local anesthesia if required.
The procedure is typically performed in an ambulatory clinic procedure room or minor surgery suite. The provider uses one of the accepted destructive modalities — cryotherapy (liquid nitrogen), electrosurgical dessication, chemical cautery (trichloroacetic acid), or laser ablation — to eradicate simple superficial external genital lesions. The workflow includes patient preparation, sterile field setup, lesion-targeted application of modality, hemostasis control, and postprocedure wound care instructions. Typical follow-up includes wound checks or return if recurrence, and pathology is rarely required unless atypical appearance warrants excisional biopsy.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
25 |